Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma. - Chinen, Yoshiaki; Tanba, Kazuna; Takagi, Ryo; Uchiyama, Hitoji; Uoshima, Nobuhiko; Shimura, Kazuho; Fuchida, Shin-ichi; Kiyota, Miki; Nakao, Mitsushige; Tsukamoto, Taku; Shimura, Yuji; Kobayashi, Tsutomu; et al. (Leukemia & Lymphoma, 2020)